0GRZ Stock Overview
RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment in the Asia-Pacific, the Middle East, the Americas, Europe, and Africa.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 0GRZ from our risk checks.
RaySearch Laboratories AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr112.80 |
| 52 Week High | kr122.60 |
| 52 Week Low | kr56.50 |
| Beta | 1.23 |
| 1 Month Change | 3.87% |
| 3 Month Change | 20.07% |
| 1 Year Change | 55.38% |
| 3 Year Change | 24.37% |
| 5 Year Change | -6.70% |
| Change since IPO | 81.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0GRZ | GB Healthcare Services | GB Market | |
|---|---|---|---|
| 7D | -5.5% | 3.0% | -0.7% |
| 1Y | 55.4% | 71.2% | -1.8% |
Return vs Industry: 0GRZ underperformed the UK Healthcare Services industry which returned 71.2% over the past year.
Return vs Market: 0GRZ exceeded the UK Market which returned -1.8% over the past year.
Price Volatility
| 0GRZ volatility | |
|---|---|
| 0GRZ Average Weekly Movement | 5.2% |
| Healthcare Services Industry Average Movement | 7.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0GRZ has not had significant price volatility in the past 3 months.
Volatility Over Time: 0GRZ's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 388 | Johan Lof | www.raysearchlabs.com |
RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment in the Asia-Pacific, the Middle East, the Americas, Europe, and Africa. It develops and markets RayStation, a treatment planning system; RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information. In addition, it offers µ-RayStation, a software platform for planning and evaluation in small animal irradiation research; RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights.
RaySearch Laboratories AB (publ) Fundamentals Summary
| 0GRZ fundamental statistics | |
|---|---|
| Market cap | kr3.98b |
| Earnings (TTM) | kr81.57m |
| Revenue (TTM) | kr1.02b |
48.8x
P/E Ratio3.9x
P/S RatioIs 0GRZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0GRZ income statement (TTM) | |
|---|---|
| Revenue | kr1.02b |
| Cost of Revenue | kr106.58m |
| Gross Profit | kr915.58m |
| Other Expenses | kr834.01m |
| Earnings | kr81.57m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 2.38 |
| Gross Margin | 89.57% |
| Net Profit Margin | 7.98% |
| Debt/Equity Ratio | 0.1% |
How did 0GRZ perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield29%
Payout RatioDoes 0GRZ pay a reliable dividends?
See 0GRZ dividend history and benchmarks| RaySearch Laboratories dividend dates | |
|---|---|
| Ex Dividend Date | May 23 2024 |
| Dividend Pay Date | May 29 2024 |
| Days until Ex dividend | 34 days |
| Days until Dividend pay date | 40 days |
Does 0GRZ pay a reliable dividends?
See 0GRZ dividend history and benchmarks